Brief report
Prescription of Alendronate and Risedronate in Men: Off-label Use in a Health Area
Prescripción de ácidos alendrónico y risedrónico en varones: uso fuera de la ficha técnica en un área de salud
Fernando León Vázqueza,
, Silvia Herrero Hernándezb, Cristina Cuerpo Trigueroa, M. José Andrés Pradoc, Luisa Cabello Ballesterosc
a Centro de Salud Universitario San Juan de la Cruz, Pozuelo de Alarcón, Madrid, Spain
b Servicio de Farmacia, Dirección Asistencial Noroeste, Gerencia de Atención Primaria, Servicio Madrileño de Salud, Majadahonda, Madrid, Spain
c Unidad Docente Multidisciplinar de Atención Familiar y Comunitaria, Dirección Asistencial Noroeste, Gerencia de Atención Primaria, Servicio Madrileño de Salud, Majadahonda, Madrid, Spain
Read
8398
Timeswas read the article
2742
Total PDF
5656
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 10 | 22 | 62 | 84 |
| 2025 9 | 0 | 72 | 72 |
| 2025 8 | 0 | 67 | 67 |
| 2025 7 | 0 | 43 | 43 |
| 2025 6 | 5 | 41 | 46 |
| 2025 5 | 149 | 57 | 206 |
| 2025 4 | 126 | 23 | 149 |
| 2025 3 | 145 | 42 | 187 |
| 2025 2 | 116 | 39 | 155 |
| 2025 1 | 93 | 40 | 133 |
| 2024 12 | 80 | 30 | 110 |
| 2024 11 | 92 | 62 | 154 |
| 2024 10 | 65 | 40 | 105 |
| 2024 9 | 74 | 26 | 100 |
| 2024 8 | 77 | 44 | 121 |
| 2024 7 | 107 | 38 | 145 |
| 2024 6 | 69 | 44 | 113 |
| 2024 5 | 80 | 38 | 118 |
| 2024 4 | 56 | 23 | 79 |
| 2024 3 | 46 | 31 | 77 |
| 2024 2 | 48 | 28 | 76 |
| 2024 1 | 45 | 21 | 66 |
| 2023 12 | 49 | 25 | 74 |
| 2023 11 | 49 | 37 | 86 |
| 2023 10 | 43 | 32 | 75 |
| 2023 9 | 82 | 34 | 116 |
| 2023 8 | 46 | 17 | 63 |
| 2023 7 | 38 | 29 | 67 |
| 2023 6 | 54 | 27 | 81 |
| 2023 5 | 61 | 21 | 82 |
| 2023 4 | 42 | 5 | 47 |
| 2023 3 | 58 | 26 | 84 |
| 2023 2 | 52 | 23 | 75 |
| 2023 1 | 37 | 25 | 62 |
| 2022 12 | 77 | 41 | 118 |
| 2022 11 | 45 | 34 | 79 |
| 2022 10 | 70 | 37 | 107 |
| 2022 9 | 52 | 37 | 89 |
| 2022 8 | 34 | 38 | 72 |
| 2022 7 | 51 | 42 | 93 |
| 2022 6 | 55 | 30 | 85 |
| 2022 5 | 47 | 59 | 106 |
| 2022 4 | 49 | 63 | 112 |
| 2022 3 | 68 | 57 | 125 |
| 2022 2 | 60 | 31 | 91 |
| 2022 1 | 52 | 41 | 93 |
| 2021 12 | 50 | 40 | 90 |
| 2021 11 | 65 | 50 | 115 |
| 2021 10 | 87 | 48 | 135 |
| 2021 9 | 80 | 48 | 128 |
| 2021 8 | 51 | 38 | 89 |
| 2021 7 | 41 | 29 | 70 |
| 2021 6 | 54 | 48 | 102 |
| 2021 5 | 67 | 50 | 117 |
| 2021 4 | 188 | 57 | 245 |
| 2021 3 | 100 | 24 | 124 |
| 2021 2 | 61 | 25 | 86 |
| 2021 1 | 66 | 22 | 88 |
| 2020 12 | 69 | 34 | 103 |
| 2020 11 | 47 | 27 | 74 |
| 2020 10 | 29 | 10 | 39 |
| 2020 9 | 58 | 34 | 92 |
| 2020 8 | 47 | 19 | 66 |
| 2020 7 | 49 | 7 | 56 |
| 2020 6 | 53 | 19 | 72 |
| 2020 5 | 40 | 17 | 57 |
| 2020 4 | 53 | 29 | 82 |
| 2020 3 | 26 | 12 | 38 |
| 2020 2 | 2 | 0 | 2 |
| 2018 12 | 2 | 0 | 2 |
| 2018 5 | 5 | 1 | 6 |
| 2018 4 | 52 | 6 | 58 |
| 2018 3 | 120 | 6 | 126 |
| 2018 2 | 37 | 4 | 41 |
| 2018 1 | 24 | 9 | 33 |
| 2017 12 | 34 | 8 | 42 |
| 2017 11 | 39 | 8 | 47 |
| 2017 10 | 34 | 8 | 42 |
| 2017 9 | 55 | 4 | 59 |
| 2017 8 | 56 | 7 | 63 |
| 2017 7 | 56 | 9 | 65 |
| 2017 6 | 90 | 15 | 105 |
| 2017 5 | 75 | 12 | 87 |
| 2017 4 | 67 | 4 | 71 |
| 2017 3 | 46 | 26 | 72 |
| 2017 2 | 23 | 7 | 30 |
| 2017 1 | 24 | 6 | 30 |
| 2016 12 | 64 | 17 | 81 |
| 2016 11 | 52 | 11 | 63 |
| 2016 10 | 72 | 14 | 86 |
| 2016 9 | 73 | 7 | 80 |
| 2016 8 | 60 | 5 | 65 |
| 2016 7 | 37 | 12 | 49 |
| 2015 12 | 2 | 0 | 2 |
| 2015 11 | 1 | 17 | 18 |
| 2015 10 | 1 | 17 | 18 |
| 2015 9 | 2 | 0 | 2 |
| 2015 8 | 2 | 0 | 2 |
| 2015 7 | 24 | 8 | 32 |
| 2015 6 | 49 | 13 | 62 |
| 2015 5 | 77 | 19 | 96 |
| 2015 4 | 78 | 29 | 107 |
| 2015 3 | 65 | 21 | 86 |
| 2015 2 | 9 | 3 | 12 |
Show all
